<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03627416</url>
  </required_header>
  <id_info>
    <org_study_id>JagiellonianU59</org_study_id>
    <nct_id>NCT03627416</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy</brief_title>
  <official_title>A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Improvement of Gait in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jakub Antczak</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hereditary spastic paraplegia (HSP) is the group of inherited disorders, characterized by&#xD;
      progressive gait disturbance. There is no established therapy. Adrenoleukodystrophy (AMN) is&#xD;
      an x-linked hereditary disease. One of its form, the adrenomyeloneuropathy has the same&#xD;
      symptoms as HSP. Current therapeutic options for AMN are very limited. Repetitive&#xD;
      Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain&#xD;
      plasticity. The purpose of this study is to compare the effectiveness of rTMS in improving&#xD;
      the HSP- and AMN-related gait disturbance and other symptoms with sham stimulation.&#xD;
&#xD;
      Intervention will include five daily sessions. In each session 1500 magnetic pulses will be&#xD;
      administered to each of both primary motor areas for lower extremities. Assessment of gait&#xD;
      and of strength and spasticity of lower extremities will be made before and after therapy, as&#xD;
      well as two weeks later.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hereditary spastic paraplegia (HSP) is a group of inherited disorders, characterized by&#xD;
      progressive gait disturbance with weakness and spasticity, which predominate in lower&#xD;
      extremities. There is no established therapy. Adrenoleukodystrophy (AMN) is an x-linked&#xD;
      hereditary disease. One of its form, the adrenomyeloneuropathy has the same symptoms as HSP.&#xD;
      Current therapeutic options for AMN are very limited. Repetitive Transcranial Magnetic&#xD;
      Stimulation (rTMS), a noninvasive method of modulation of brain plasticity proved to be&#xD;
      effective in improving the gait performance in several conditions such as Parkinson Disease,&#xD;
      vascular Parkinsonism, partial spinal cord injury and in post-stroke paresis. Previous&#xD;
      studies documented also altered cortical excitability in HSP patients.&#xD;
&#xD;
      The purpose of this study is to compare the effectiveness of 10 hertz (Hz) rTMS over the&#xD;
      primary motor cortices in improving the gait and strength and spasticity of lower extremities&#xD;
      with sham stimulation in HSP and AMN patients.&#xD;
&#xD;
      Intervention will include five daily sessions. In each session 1500 magnetic pulses will be&#xD;
      administered to each of both primary motor areas for lower extremities. Assessment of gait&#xD;
      and of strength and spasticity of lower extremities will be made before and after therapy, as&#xD;
      well as two weeks later.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>16 patients with HSP or AMN will receive either active and sham stimulation in random order</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Sham stimulation will be provided by holding the stimulating coil perpendicularly to the scalp, which assures similar impression as during active stimulation but prevents significant magnetic field to reach the brain tissue.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline Walking Time in 10 Meter Walk Test to the Measurement Taken Directly After rTMS</measure>
    <time_frame>Before rTMS, directly (on the same day) after rTMS</time_frame>
    <description>Change in time of walking barefoot the distance of 10 meters with maximal speed, but safely, between baseline and directly after rTMS.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Timed up and go Test</measure>
    <time_frame>Baseline, directly (on the same day) after rTMS and 14 days later</time_frame>
    <description>Time of standing up from a chair, walking three metres to cross a line drawn 3 meters ahead and going back to sit down on the chair.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Medical Research Council Scale (MRC)</measure>
    <time_frame>Baseline, directly (on the same day) after rTMS and 14 days later</time_frame>
    <description>Change in bilateral assessment of the strength of following movements: hip flexion, knee flexion and extension, ankle flexion and extension. Assessment will be made according to six degrees (0 to 5) MRC scale, with higher values representing stronger movements, which is better outcome. Values are averaged from all movements tested.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Ashworth Scale</measure>
    <time_frame>Baseline, directly (on the same day) after rTMS and 14 days later</time_frame>
    <description>Bilateral assessment of spasticity in following movements: hip flexion, knee flexion and extension, ankle flexion and extension. Assessment will be made according to six degrees (0 to 5) Modified Ashworth Scale, with higher values representing more severe spasticity, which is worse outcome. Values are averaged from all movements tested.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline Walking Time in 10 Meter Walk Test to the Measurement Taken Two Weeks After rTMS</measure>
    <time_frame>Baseline, 14 days after rTMS</time_frame>
    <description>Change in time of walking barefoot the distance of 10 meters with maximal speed, but safely, between baseline and 14 days after finishing rTMS therapy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Hereditary Spastic Paraplegia</condition>
  <condition>Adrenomyeloneuropathy</condition>
  <arm_group>
    <arm_group_label>active rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_label>active rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of hereditary spastic paraplegia - confirmed genetically, on the basis of&#xD;
             family history or on exclusion or diagnosis of adrenomyeloneuropathy - confirmed&#xD;
             genetically or by the elevated plasma very long chain fatty acid or on family history&#xD;
&#xD;
          -  Gait disturbances affecting daily activities&#xD;
&#xD;
          -  Ability to walk 10 meters without assistance or with crutches or with rollator walker&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of signs or symptoms indicating other than HSP or AMN ethiology of gait&#xD;
             disturbances&#xD;
&#xD;
          -  Contraindications for rTMS as listed by the Guidelines of the International Federation&#xD;
             of Clinical Neurophysiology (IFCN 2009) i.e. seizure in the past, epilepsy, presence&#xD;
             of magnetic material in the reach of magnetic field, pregnancy, likelihood to get&#xD;
             pregnant, intracranial electrodes, cardiac pacemaker or intracardiac lines, frequent&#xD;
             syncopes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jakub M Antczak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jagiellonian University Medical College, Department of Neurology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jagiellonian University Medical College, Department of Neurology</name>
      <address>
        <city>Krak√≥w</city>
        <zip>31503</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.</citation>
    <PMID>19833552</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 23, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <results_first_submitted>February 9, 2021</results_first_submitted>
  <results_first_submitted_qc>August 30, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 27, 2021</results_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Jakub Antczak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hereditary spastic paraplegia</keyword>
  <keyword>repetitive transcranial magnetic stimulation</keyword>
  <keyword>disturbed gait</keyword>
  <keyword>Adrenomyeloneuropthy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
    <mesh_term>Spastic Paraplegia, Hereditary</mesh_term>
    <mesh_term>Adrenoleukodystrophy</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT03627416/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We recruited 15 patients meeting inclusion criteria. One patient dropped out due to seizure, when he was in active treatment.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Active rTMS First, Then Sham rTMS</title>
          <description>First intervention: 10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
The washout will last at least one month.&#xD;
Second intervention:&#xD;
Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
        </group>
        <group group_id="P2">
          <title>Sham rTMS, Then Active rTMS</title>
          <description>First intervention: Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
The washout will last at least one month.&#xD;
Second intervention: 10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active rTMS, Then Sham rTMS</title>
          <description>First intervention:&#xD;
10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
The washout period will last at least one month.&#xD;
Second intervention:&#xD;
Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
        </group>
        <group group_id="B2">
          <title>Sham rTMS, Then Active rTMS</title>
          <description>First intervention:&#xD;
Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
The washout period will last at least one month.&#xD;
Second intervention:&#xD;
10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.5" spread="11.9"/>
                    <measurement group_id="B2" value="41.7" spread="7.5"/>
                    <measurement group_id="B3" value="44.8" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Poland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Central motor conduction time</title>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.2" spread="3.4"/>
                    <measurement group_id="B2" value="20.3" spread="6.6"/>
                    <measurement group_id="B3" value="19.1" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Amplitude of motor evoked potentials</title>
          <units>millivolts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.1" spread="0.6"/>
                    <measurement group_id="B2" value="0.7" spread="0.5"/>
                    <measurement group_id="B3" value="0.9" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Motor threshold for left abductor hallucis</title>
          <units>percentage of the maximal stimulator out</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.1" spread="7.5"/>
                    <measurement group_id="B2" value="63.5" spread="8.0"/>
                    <measurement group_id="B3" value="63.9" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Motor threshold for the right abductor hallucis</title>
          <units>Percentage of the max stimulator output</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.4" spread="12.1"/>
                    <measurement group_id="B2" value="62.8" spread="8.3"/>
                    <measurement group_id="B3" value="62.0" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline Walking Time in 10 Meter Walk Test to the Measurement Taken Directly After rTMS</title>
        <description>Change in time of walking barefoot the distance of 10 meters with maximal speed, but safely, between baseline and directly after rTMS.</description>
        <time_frame>Before rTMS, directly (on the same day) after rTMS</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active rTMS</title>
            <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS</title>
            <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline Walking Time in 10 Meter Walk Test to the Measurement Taken Directly After rTMS</title>
          <description>Change in time of walking barefoot the distance of 10 meters with maximal speed, but safely, between baseline and directly after rTMS.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.41" spread="16.42"/>
                    <measurement group_id="O2" value="1.70" spread="8.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Timed up and go Test</title>
        <description>Time of standing up from a chair, walking three metres to cross a line drawn 3 meters ahead and going back to sit down on the chair.</description>
        <time_frame>Baseline, directly (on the same day) after rTMS and 14 days later</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active rTMS</title>
            <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS</title>
            <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Timed up and go Test</title>
          <description>Time of standing up from a chair, walking three metres to cross a line drawn 3 meters ahead and going back to sit down on the chair.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline vs. after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.72" spread="13.90"/>
                    <measurement group_id="O2" value="0.18" spread="4.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline vs. 14 days later</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.92" spread="7.29"/>
                    <measurement group_id="O2" value="0.78" spread="7.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Medical Research Council Scale (MRC)</title>
        <description>Change in bilateral assessment of the strength of following movements: hip flexion, knee flexion and extension, ankle flexion and extension. Assessment will be made according to six degrees (0 to 5) MRC scale, with higher values representing stronger movements, which is better outcome. Values are averaged from all movements tested.</description>
        <time_frame>Baseline, directly (on the same day) after rTMS and 14 days later</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active rTMS</title>
            <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS</title>
            <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Medical Research Council Scale (MRC)</title>
          <description>Change in bilateral assessment of the strength of following movements: hip flexion, knee flexion and extension, ankle flexion and extension. Assessment will be made according to six degrees (0 to 5) MRC scale, with higher values representing stronger movements, which is better outcome. Values are averaged from all movements tested.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline vs. directly after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0.06" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline vs. 14 days later</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.27"/>
                    <measurement group_id="O2" value="0" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Ashworth Scale</title>
        <description>Bilateral assessment of spasticity in following movements: hip flexion, knee flexion and extension, ankle flexion and extension. Assessment will be made according to six degrees (0 to 5) Modified Ashworth Scale, with higher values representing more severe spasticity, which is worse outcome. Values are averaged from all movements tested.</description>
        <time_frame>Baseline, directly (on the same day) after rTMS and 14 days later</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active rTMS</title>
            <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS</title>
            <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Ashworth Scale</title>
          <description>Bilateral assessment of spasticity in following movements: hip flexion, knee flexion and extension, ankle flexion and extension. Assessment will be made according to six degrees (0 to 5) Modified Ashworth Scale, with higher values representing more severe spasticity, which is worse outcome. Values are averaged from all movements tested.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline vs. after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="0.50"/>
                    <measurement group_id="O2" value="0" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline vs. 14 days later</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.27" spread="0.46"/>
                    <measurement group_id="O2" value="-0.11" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline Walking Time in 10 Meter Walk Test to the Measurement Taken Two Weeks After rTMS</title>
        <description>Change in time of walking barefoot the distance of 10 meters with maximal speed, but safely, between baseline and 14 days after finishing rTMS therapy.</description>
        <time_frame>Baseline, 14 days after rTMS</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active rTMS</title>
            <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS</title>
            <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline Walking Time in 10 Meter Walk Test to the Measurement Taken Two Weeks After rTMS</title>
          <description>Change in time of walking barefoot the distance of 10 meters with maximal speed, but safely, between baseline and 14 days after finishing rTMS therapy.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.84" spread="17.52"/>
                    <measurement group_id="O2" value="0.93" spread="6.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Active rTMS</title>
          <description>10 hertz (Hz) rTMS will be administered over bilateral primary motor areas for the muscles of lower extremities. Therapy will include five daily sessions (on consecutive week days). In every sessions 3000 magnetic pulses of 90% of the resting motor threshold intensity will be elicited.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
        </group>
        <group group_id="E2">
          <title>Sham rTMS</title>
          <description>Sham stimulation will mimic the active one except that the stimulating coil will be held perpendicularly to the scalp, which assures similar impression as the active stimulation but prevents that significant magnetic field will reach brain tissue.&#xD;
rTMS: high frequency rTMS to induce the long term potentiation of primary motor areas for the muscles of lower extremities</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Seizure</sub_title>
                <description>In one patient a seizure occurred during the third session of real stimulation. It began with a tonic flexion of the hip and knee. Then, a loss of consciousness and generalized convulsions followed. The seizure resolved after three minutes.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Sleplessness</sub_title>
                <description>One female participant (62 years of age) complained about sleeplessness after the first two sessions of active stimulation.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Head ache</sub_title>
                <description>Mild head ache during first sessions of active rTMS</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limited number of sessions, which may decrease the magnitude of the therapeutic effect.&#xD;
The abundant pharmacotherapy with baclofen could considerably reduce observed effects on spasticity.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Jakub Antczak</name_or_title>
      <organization>Jagiellonian University Medical College</organization>
      <phone>+48 795 421 153</phone>
      <email>jantczak@uj.edu.pl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

